Trial intelligence / Profile preview

Sertraline for Depression in CHF

NCT00078286Phase 3Completed

Sponsor
Duke University
Start
Nov 2003
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sertraline in major depressive disorder (MDD), sponsored by Duke University. Started Nov 2003; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00078286.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00078286.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call